Indeed, it has been reported that high levels of LAG-3+ T cells are an independent predictor of poor PFS and OS in HCC patients (36), which is consistent with our analysis of the ICB-naïve cohort (Figure 2). The gene discussed is LAG3; the disease is hepatocellular carcinoma.